Table 4 Anticipated physiochemical characteristics of SirReal2 and the inspected NPAtlas compounds as promising SIRT2 inhibitors.
From: In silico drug discovery of SIRT2 inhibitors from natural source as anticancer agents
NPAtlas Code | MlogP | HBA | Nrotb | HBD | TPSA | MW | %ABS |
|---|---|---|---|---|---|---|---|
SirReal2 | 2.65 | 4 | 7 | 1 | 121.31 | 420.55 | 67.1% |
NPA009578 | 4.67 | 5 | 6 | 2 | 68.15 | 442.50 | 85.5% |
NPA006805 | 1.86 | 4 | 13 | 4 | 114.53 | 524.61 | 69.5% |
NPA001884 | 5.11 | 4 | 5 | 0 | 111.02 | 506.59 | 70.7% |
